105 related articles for article (PubMed ID: 21459569)
1. PERIOD1 (PER1) has anti-apoptotic effects, and PER3 has pro-apoptotic effects during cisplatin (CDDP) treatment in human gingival cancer CA9-22 cells.
Sato F; Wu Y; Bhawal UK; Liu Y; Imaizumi T; Morohashi S; Kato Y; Kijima H
Eur J Cancer; 2011 Jul; 47(11):1747-58. PubMed ID: 21459569
[TBL] [Abstract][Full Text] [Related]
2. PERIOD1 is an anti-apoptotic factor in human pancreatic and hepatic cancer cells.
Sato F; Nagata C; Liu Y; Suzuki T; Kondo J; Morohashi S; Imaizumi T; Kato Y; Kijima H
J Biochem; 2009 Dec; 146(6):833-8. PubMed ID: 19675098
[TBL] [Abstract][Full Text] [Related]
3. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II).
Mizutani Y; Yoshida O; Bonavida B
J Urol; 1998 Aug; 160(2):561-70. PubMed ID: 9679929
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of vascular endothelial growth factor expression mediated by cisplatin in human ovarian cancer cells.
Zhong XS; Liu LZ; Skinner HD; Cao Z; Ding M; Jiang BH
Biochem Biophys Res Commun; 2007 Jun; 358(1):92-8. PubMed ID: 17470361
[TBL] [Abstract][Full Text] [Related]
5. Effects of the biological clock gene Bmal1 on tumour growth and anti-cancer drug activity.
Zeng ZL; Wu MW; Sun J; Sun YL; Cai YC; Huang YJ; Xian LJ
J Biochem; 2010 Sep; 148(3):319-26. PubMed ID: 20576619
[TBL] [Abstract][Full Text] [Related]
6. BHLH transcription factor DEC2 regulates pro-apoptotic factor Bim in human oral cancer HSC-3 cells.
Wu Y; Sato F; Bhawal UK; Kawamoto T; Fujimoto K; Noshiro M; Seino H; Morohashi S; Kato Y; Kijima H
Biomed Res; 2012 Apr; 33(2):75-82. PubMed ID: 22572381
[TBL] [Abstract][Full Text] [Related]
7. Enhancement effect of adenovirus-mediated antisense c-myc and caffeine on the cytotoxicity of cisplatin in osteosarcoma cell lines.
Xie XK; Yang DS; Ye ZM; Tao HM
Chemotherapy; 2009; 55(6):433-40. PubMed ID: 19996588
[TBL] [Abstract][Full Text] [Related]
8. The circadian gene per1 plays an important role in cell growth and DNA damage control in human cancer cells.
Gery S; Komatsu N; Baldjyan L; Yu A; Koo D; Koeffler HP
Mol Cell; 2006 May; 22(3):375-82. PubMed ID: 16678109
[TBL] [Abstract][Full Text] [Related]
9. Expression of livin in gastric cancer and induction of apoptosis in SGC-7901 cells by shRNA-mediated silencing of livin gene.
Wang TS; Ding QQ; Guo RH; Shen H; Sun J; Lu KH; You SH; Ge HM; Shu YQ; Liu P
Biomed Pharmacother; 2010 May; 64(5):333-8. PubMed ID: 19914791
[TBL] [Abstract][Full Text] [Related]
10. Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers.
Chen ST; Choo KB; Hou MF; Yeh KT; Kuo SJ; Chang JG
Carcinogenesis; 2005 Jul; 26(7):1241-6. PubMed ID: 15790588
[TBL] [Abstract][Full Text] [Related]
11. Thioredoxin is downstream of Smad7 in a pathway that promotes growth and suppresses cisplatin-induced apoptosis in pancreatic cancer.
Arnold NB; Ketterer K; Kleeff J; Friess H; Büchler MW; Korc M
Cancer Res; 2004 May; 64(10):3599-606. PubMed ID: 15150118
[TBL] [Abstract][Full Text] [Related]
12. [Effects of over-expressed Smac gene coupling with cisplatin on proliferation and apoptosis of hepatocarcinoma cells].
Guo CX; Li YB; DU HY; Liu Y; Sun L; Jin MH; Sun ZW
Zhonghua Gan Zang Bing Za Zhi; 2008 Sep; 16(9):674-7. PubMed ID: 18822208
[TBL] [Abstract][Full Text] [Related]
13. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance.
Brenes O; Arce F; Gätjens-Boniche O; Díaz C
Biomed Pharmacother; 2007 Jul; 61(6):347-55. PubMed ID: 17399942
[TBL] [Abstract][Full Text] [Related]
14. Arsenic trioxide and cisplatin synergism increase cytotoxicity in human ovarian cancer cells: therapeutic potential for ovarian cancer.
Zhang N; Wu ZM; McGowan E; Shi J; Hong ZB; Ding CW; Xia P; Di W
Cancer Sci; 2009 Dec; 100(12):2459-64. PubMed ID: 19769630
[TBL] [Abstract][Full Text] [Related]
15. Dual apoptotic effect of Xrel3 c-Rel/NF-kappaB homolog in human cervical cancer cells.
Shehata M; Shehata M; Shehata F; Pater A
Cell Biol Int; 2004; 28(12):895-904. PubMed ID: 15566959
[TBL] [Abstract][Full Text] [Related]
16. Expression of inducible nitric oxide synthase during cisplatin-based chemotherapy for gastric cancer.
Ikeguchi M; Ueta T; Kaibara N
In Vivo; 2002; 16(3):185-90. PubMed ID: 12182114
[TBL] [Abstract][Full Text] [Related]
17. Solamargine induces apoptosis and sensitizes breast cancer cells to cisplatin.
Shiu LY; Chang LC; Liang CH; Huang YS; Sheu HM; Kuo KW
Food Chem Toxicol; 2007 Nov; 45(11):2155-64. PubMed ID: 17619073
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
19. Clock gene mouse period2 overexpression inhibits growth of human pancreatic cancer cells and has synergistic effect with cisplatin.
Oda A; Katayose Y; Yabuuchi S; Yamamoto K; Mizuma M; Shirasou S; Onogawa T; Ohtsuka H; Yoshida H; Hayashi H; Rikiyama T; Kim H; Choe Y; Kim K; Son H; Motoi F; Egawa S; Unno M
Anticancer Res; 2009 Apr; 29(4):1201-9. PubMed ID: 19414365
[TBL] [Abstract][Full Text] [Related]
20. Resistance to cisplatin-induced apoptosis via PI3K-dependent survivin expression in a rat hepatoma cell line.
Asechi H; Hatano E; Nitta T; Tada M; Iwaisako K; Tamaki N; Nagata H; Narita M; Yanagida A; Ikai I; Uemoto S
Int J Oncol; 2010 Jul; 37(1):89-96. PubMed ID: 20514400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
